Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
{"title":"Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial","authors":"D. Harnois","doi":"10.1016/J.YGAS.2011.07.125","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23790,"journal":{"name":"Yearbook of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"139","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Yearbook of Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/J.YGAS.2011.07.125","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
